ADPT Adaptive Biotechnologies
- 3.500
- -0.060-1.69%
- 3.470
- -0.030-0.86%
Adaptive Biotechnologies News
Why Adaptive Biotechnologies Topped the Market Today
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2024 Earnings Call Transcript
Earnings Call Summary | Adaptive Biotechnologies(ADPT.US) Q1 2024 Earnings Conference
The following is a summary of the Adaptive Biotechnologies Corporation (ADPT) Q1 2024 Earnings Call Transcript:Financial Performance:Adaptive Biotechnologies reported Q1 2024 revenue of $41.99 million
Analysts Offer Insights on Healthcare Companies: Adaptive Biotechnologies (ADPT), Veracyte (VCYT) and Nevro Corp (NVRO)
Analysts Offer Insights on Healthcare Companies: Clover Health Investments (CLOV), Cogent Biosciences (COGT) and Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Corp (ADPT) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Compared to Estimates, Adaptive Biotechnologies (ADPT) Q1 Earnings: A Look at Key Metrics
Adaptive Biotechnologies Q1 2024 Earnings: Revenue Beats Estimates Amidst Challenges
Adaptive Biotechnologies | 10-Q: Quarterly report
Adaptive Biotechnologies Q1 2024 GAAP EPS $(0.33) Beats $(0.35) Estimate, Sales $41.873M Beat $38.784M Estimate
Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.35) by 5.71 percent. This is a 17.5 percent increase over losses
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, Vs. Street Est of $38.8M
04:36 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q1 Revenue $41.9M, vs. Street Est of $38.8M
Adaptive Biotechnologies 1Q Loss/Shr 33c >ADPT
Adaptive Biotechnologies 1Q Loss/Shr 33c >ADPT
Press Release: Adaptive Biotechnologies Reports First Quarter 2024 Financial Results
Adaptive Biotechnologies Reports First Quarter 2024 Financial Results SEATTLE, May 07, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (Nasdaq: ADPT), a com
Netflix, ON Semiconductor And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were lower this morning, with the Nasdaq futures declining over 100 points on Friday.Shares of Netflix, Inc. (NASDAQ:NFLX) fell sharply in today's pre-market trading following first
Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
Shares of Wang & Lee Group, Inc. (NASDAQ:WLGS) rose sharply in today's pre-market trading after the company reported a year-over-year increase in FY23 financial results.Wang & Lee Group posted a FY23
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
Adaptive Biotechnologies Names Kyle Piskel New CFO
BTIG Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny
To the annoyance of some shareholders, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares are down a considerable 33% in the last month, which continues a horrid run for the company.
Analysis
Price Target
No Data
